INS and type 2 diabetes mellitus: Lower plasma SMOC1 levels in insulin-resistant individuals (Montgomery et al., 2020)No evidence that plasma SMOC1 levels are causally associated with T2DM, MASLD, and glycemic traits (Ghodsian et al., 2021)